北米のPoint Of Care Diagnostics市場規模、シェア、動向分析レポート製品別（感染症、グルコース検査、心臓マーカー）、タイプ別、エンドユース別（クリニック、ホームケア、病院）、国別、セグメント予測、2023～2030年

North America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By Type, By End-use (Clinics, Home Care, Hospitals), By Country, And Segment Forecasts, 2023 - 2030

北米のPoint Of Care Diagnostics市場の成長・トレンド Grand View Research, Inc.の最新レポートによると、北米のポイントオブケア診断市場規模は2030年までに284億6000万米ドルに達し、予測期間中にCAGR 6.2... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Grand View Research グランドビューリサーチ	2023年1月27日	US$5,950 シングルユーザライセンス(印刷不可) ライセンス・価格情報注文方法はこちら	180	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

北米のPoint Of Care Diagnostics市場の成長・トレンド

Grand View Research, Inc.の最新レポートによると、北米のポイントオブケア診断市場規模は2030年までに284億6000万米ドルに達し、予測期間中にCAGR 6.2％で拡大すると予測されています。この成長は、高齢者人口の増加や、すぐに結果を出せるポイントオブケア（POC）診断テストの能力に起因していると考えられます。さらに、政府機関や民間機関からの資金提供の増加は、業界の成長を促進する重要な要因となっています。また、同地域におけるモバイル診断機器の導入の増加も、POC検査の需要を促進する重要な要因の一つとなっています。

米国国防総省（DOD）、NIH、ビル＆メリンダ・ゲイツ財団のような民間財団など、複数のソースからの資金提供の増加が、市場の成長を促進すると予想されます。例えば、Grand Challenges CanadaとBill & Melinda Gates Foundationは、POC診断薬に関する共同イニシアチブを立ち上げました。これらの組織は、さまざまな診断コンポーネントを開発し、「プラグアンドプレイ」の特徴を持ち、さまざまな開発者の多様なテストを実行できる相互運用可能なPOCプラットフォームに統合することに関与しています。各検査を単一のインターフェースで共通のプラットフォームに組み込み、さまざまな検体をさまざまなアプローチで分析できるようにするための研究が行われています。

このような機関は、カリフォルニア工科大学、ダートマス大学、セブンスセンス・バイオシステムズなど、さまざまな組織に対してPOC診断薬の開発プロジェクトに資金援助を行っています。さらに、NIHは、Point-of-Care Technologies Research Networkを通じて、感染症やがんのスクリーニング、プライマリケアのためのこれらの技術の開発に資金援助を行っています。2022年8月、Nanopath, Inc.は、Medtech Convergence FundとNorwest Venture Partnersから、Green D VenturesとGingerbread Capitalの参加を得て、1千万米ドルの資金提供を受けました。この資金は、女性の健康のためのPOC診断の開発に役立つと思われます。

同市場で事業を展開する主要企業は、新製品開発のための協業に注力している。例えば、2021年12月、QIAGENとDenovo Biopharma LLCは、血液ベースのコンパニオン診断テストを確立するための提携を発表した。さらに、各社は診断検査の効率化を図るため、革新的な技術の投入にも力を入れている。例えば、2021年、F. Hoffmann-La Roche Ltdは新しい血糖値測定器Accu-Chek Instantシステムを発売し、同社の個別化糖尿病管理事業の拡大に貢献しました。

北米のPoint Of Care Diagnostics市場レポートハイライト

- 市場全体の成長は、優れた効率性と最小限の診断所要時間により、ポイントオブケア検査が重視されるようになったことに起因している

- 米国国防総省（DOD）、NIH、ビル＆メリンダ・ゲイツ財団などの民間財団を含む複数のソースからの資金提供の増加は、北米における新しいPoC診断技術の発売を増加させると期待されます。

- 感染症分野は、COVID-19診断キットの大幅な普及と呼吸器疾患用の新しいPoCキットの導入により、最大の市場シェアを獲得しました。

- 2022年には、クリニックのエンドユースセグメントが最も高い収益シェアで市場を支配しています。これは、利便性から診療所を好む人口が多いことに起因している

- 2022年の北米PoC診断業界では、厳格な当局規制により、LDTタイプセグメントが限界的なシェアを占めた

- 主要プレイヤーの存在と先端技術開発に対する政府からの支援の高まりにより、2022年の市場は米国が支配した

ページTOPに戻る

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Definitions
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 Gvr’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details Of Primary Research
1.6 Information Or Data Analysis
1.6.1 Market Categorization
1.6.2 Point - Of - Care Testing
1.6.2.1 Poc - End - Use Penetration Mapping
1.6.3 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Approach 2: Country - Wise Market Estimation Using The Bottom - Up Approach
1.9 North America Market: Cagr Calculation
1.10 List Of Secondary Sources
1.11 List Of Primary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.1.3 Molecular Technology Intervention
3.1.3.1 Key Factors Considered For Analyzing Molecular Technology Interventions Across Point-Of-care (Poc) Testing
3.2 Penetration And Growth Prospect Mapping For Poc Products, 2022
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Introduction Of Clia - Waived Tests
3.3.1.2 Rise In Funding From Government And Private Institutions
3.3.1.3 Growing Geriatric Population
3.3.1.4 Growing Prevalence Of Targeted Diseases
3.3.1.5 Growing Demand For Home Healthcare And Introduction Of Advanced Technology - Enabled Products
3.3.2 Market Restraint Analysis
3.3.2.1 Presence Of Ambiguous Regulatory Framework
3.3.3 Market Challenge Analysis
3.3.3.1 Poc Devices Pose Challenges In Maintaining Quality Standards
3.3.4 Market Opportunity Analysis
3.3.4.1 Networking & Remote Access Integration Of Poc Diagnostics Products
3.3.4.1.1 Smartphone Orientation
3.3.4.1.2 Embedded Vision - Based Solutions
3.3.4.1.3 Digital Technologies
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
3.6 Market Entry Strategies
3.7 Price - Cost - Margin Analysis For Poc Testing
3.8 User Perspective Analysis
3.8.1 Consumer Behavior Analysis
3.9 Technology Overview
3.10 Poc Diagnostics: Market Influencers
3.10.1 High Sensitivity
3.10.2 Shift To Molecular Diagnostics
3.10.3 Glucose Testing
3.10.4 Hba1c Testing
3.10.5 Coagulation Testing
3.10.6 Fertility Testing
3.10.7 Infectious Disease
3.10.8 Cardiac Markers
3.10.9 Thyroid - Stimulating Hormone
3.10.10 Hematology
3.10.11 Primary Care Systems
3.10.12 Decentralized Clinical Chemistry
3.10.13 Feces
3.10.14 Lipid Testing
3.10.15 Cancer Marker
3.10.16 Blood Gas/Electrolytes
3.10.17 Ambulatory Chemistry
3.10.18 Drug Of Abuse (Doa) Testing
3.10.19 Urinalysis
3.11 Covid - 19 Impact Analysis
3.12 Overview
3.12.1 Covid - 19 Point - Of - Care Diagnostics: Technology Overview
3.12.2 Covid - 19 Point - Of - Care Diagnostics: Regulatory Overview
3.12.3 Covid - 19 Point - Of - Care Diagnostics: Competitive Landscape
Chapter 4 Product Business Analysis
4.1 North America Point - Of - Care (Poc) Diagnostics Market: Product Movement Analysis
4.2 Glucose Testing
4.2.1 Glucose Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Glucose Testing Market, By End - Use
4.2.2.1 Glucose Testing Market, By Hospital
4.2.2.2 Glucose Testing Market, By Laboratories
4.2.2.3 Glucose Testing Market, By Home Care
4.2.2.4 Glucose Testing Market, By Clinic
4.2.2.5 Glucose Testing Market, By Physician Office
4.2.2.6 Glucose Testing Market, By Pharmacy & Retail Clinics
4.2.2.7 Glucose Testing Market, By Non - Practice Clinics
4.2.2.8 Glucose Testing Market, By Urgent Care Clinics
4.2.2.9 Glucose Testing Market, By Others
4.2.2.10 Glucose Testing Market, By Rural Health Clinic
4.2.2.11 Glucose Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.2.3 Glucose Testing Market, By Disease
4.2.3.1 Diabetes
4.2.3.2 Glucose Testing Market, By Diabetes
4.2.3.3 Others
4.2.3.4 Glucose Testing Market, By Others
4.3 Hba1c Testing
4.3.1 Hba1c Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Hba1c Testing Market, By End - Use
4.3.2.1 Hba1c Testing Market, By Hospital
4.3.2.2 Hba1c Testing Market, By Laboratories
4.3.2.3 Hba1c Testing Market, By Home Care
4.3.2.4 Hba1c Testing Market, By Clinic
4.3.2.5 Hba1c Testing Market, By Physician Office
4.3.2.6 Hba1c Testing Market, By Pharmacy & Retail Clinics
4.3.2.7 Hba1c Testing Market, By Non - Practice Clinics
4.3.2.8 Hba1c Testing Market, By Urgent Care Clinics
4.3.2.9 Hba1c Testing Market, By Others
4.3.2.10 Hba1c Testing Market, By Rural Health Clinic
4.3.2.11 Hba1c Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.3.3 Hba1c Testing Market, By Disease
4.3.3.1 Diabetes
4.3.3.2 Hba1c Testing Market, By Diabetes
4.3.3.3 Others
4.3.3.4 Hba1c Testing Market, By Others
4.4 Coagulation Testing
4.4.1 Coagulation Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Coagulation Testing Market, By End - Use
4.4.2.1 Coagulation Testing Market, By Hospital
4.4.2.2 Coagulation Testing Market, By Laboratories
4.4.2.3 Coagulation Testing Market, By Home Care
4.4.2.4 Coagulation Testing Market, By Clinic
4.4.2.5 Coagulation Testing Market, By Physician Office
4.4.2.6 Coagulation Testing Market, By Pharmacy & Retail Clinics
4.4.2.7 Coagulation Testing Market, By Non - Practice Clinics
4.4.2.8 Coagulation Testing Market, By Urgent Care Clinics
4.4.2.9 Coagulation Testing Market, By Others
4.4.2.10 Coagulation Testing Market, By Rural Health Clinic
4.4.2.11 Coagulation Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.4.3 Coagulation Testing Market, By Disease
4.4.3.1 Thrombosis
4.4.3.2 Coagulation Testing Market, By Thrombosis
4.4.3.3 Hemophilia
4.4.3.4 Coagulation Testing Market, By Hemophilia
4.4.3.5 Others
4.4.3.6 Coagulation Testing Market, By Others
4.5 Fertility/Pregnancy
4.5.1 Fertility/Pregnancy Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.2 Fertility Testing Market, By End - Use
4.5.2.1 Fertility Testing Market, By Hospital
4.5.2.2 Fertility Testing Market, By Laboratories
4.5.2.3 Fertility Testing Market, By Home Care
4.5.2.4 Fertility Testing Market, By Clinic
4.5.2.5 Fertility Testing Market, By Physician Office
4.5.2.6 Fertility Testing Market, By Pharmacy & Retail Clinics
4.5.2.7 Fertility Testing Market, By Non - Practice Clinics
4.5.2.8 Fertility Testing Market, By Urgent Care Clinics
4.5.2.9 Fertility Testing Market, By Others
4.5.2.10 Fertility Testing Market, By Rural Health Clinic
4.5.2.11 Fertility Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.5.3 Fertility Testing Market, By Type
4.5.3.1 Lh - Ovulation Elite Tes
4.5.3.2 Fertility Testing Market, By Lh - Ovulation Elite Test
4.5.3.3 Hcg - Pregnancy Tests
4.5.3.4 Fertility Testing Market, By Hcg - Pregnancy Tests
4.5.3.5 Fertility Tests
4.5.3.6 Fertility Testing Market, By Fertility Tests
4.5.3.7 Others
4.5.3.8 Fertility Testing Market, By Others
4.6 Infectious Disease Testing
4.6.1 Infectious Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6.2 Infectious Disease Testing Market, By End - Use
4.6.2.1 Infectious Disease Testing Market, By Hospital
4.6.2.2 Infectious Disease Testing Market, By Laboratories
4.6.2.3 Infectious Disease Testing Market, By Home Care
4.6.2.4 Infectious Disease Testing Market, By Clinic
4.6.2.5 Infectious Disease Testing Market, By Physician Office
4.6.2.6 Infectious Disease Testing Market, By Pharmacy & Retail Clinics
4.6.2.7 Infectious Disease Testing Market, By Non - Practice Clinics
4.6.2.8 Infectious Disease Testing Market, By Urgent Care Clinics
4.6.2.9 Infectious Disease Testing Market, By Others
4.6.2.10 Infectious Disease Testing Market, By Rural Health Clinic
4.6.2.11 Infectious Disease Testing Market, By Federally Qualified Health Clinic (Fqhc)
4.6.3 Infectious Disease Testing Market, By Disease
4.6.3.1 Hiv Poc
4.6.3.2 Infectious Disease Testing Market, By Hiv Poc
4.6.3.3 Clostridium Difficile Poc
4.6.3.4 Infectious Disease Testing Market, By Clostridium Difficile Poc
4.6.3.5 Hbv Poc
4.6.3.6 Infectious Disease Testing Market, By Hbv Poc
4.6.3.7 Pneumonia Or Streptococcus - Associated Infections
4.6.3.8 Infectious Disease Testing Market, By Pneumonia Or Streptococcus Associated Infections
4.6.3.9 Respiratory Syncytial Virus Poc
4.6.3.10 Infectious Disease Testing Market, By Respiratory Syncytial Virus (Rsv) Poc
4.6.3.11 Hpv Poc
4.6.3.12 Infectious Disease Testing Market, By Hpv Poc
4.6.3.13 Influenza/Flu Poc
4.6.3.14 Infectious Disease Testing Market, By Influenza/Flu Poc
4.6.3.15 Hcv Poc
4.6.3.16 Infectious Disease Testing Market, By Hcv Poc
4.6.3.17 Mrsa Poc
4.6.3.18 Infectious Disease Testing Market, By Mrsa Poc
4.6.3.19 Tb And Drug - Resistant Tb Poc
4.6.3.20 Infectious Disease Testing Market, By Tb And Drug - Resistant Tb Poc
4.6.3.21 Hsv Poc
4.6.3.22 Infectious Disease Testing Market, By Hsv Poc
4.6.3.23 Covid - 19
4.6.3.24 Infectious Disease Testing Market, By Covid - 19
4.6.3.25 Other Infectious Diseases
4.6.3.26 Infectious Disease Testing Market, By Other Infectious Diseases
4.7 Cardiac Markers
4.7.1 Cardiac Markers Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.7.2 Cardiac Markers Market, By End - Use
4.7.2.1 Cardiac Markers Market, By Hospital
4.7.2.2 Cardiac Markers Market, By Laboratories
4.7.2.3 Cardiac Markers Market, By Home Care
4.7.2.4 Cardiac Markers Market, By Clinic
4.7.2.5 Cardiac Markers Market, By Physician Office
4.7.2.6 Cardiac Markers Market, By Pharmacy & Retail Clinics
4.7.2.7 Cardiac Markers Market, By Non - Practice Clinics
4.7.2.8 Cardiac Markers Market, By Urgent Care Clinics
4.7.2.9 Cardiac Markers Market, By Others
4.7.2.10 Cardiac Markers Market, By Rural Health Clinic
4.7.2.11 Cardiac Markers Market, By Federally Qualified Health Clinic (Fqhc)
4.7.3 Cardiac Markers Market, By Disease
4.7.3.1 Acute Coronary Syndrome
4.7.3.2 Cardiac Markers Market, By Acute Coronary Syndrome
4.7.3.3 Myocardial Infarction
4.7.3.4 Cardiac Markers Market, By Myocardial Infarction
4.7.3.5 Congestive Heart Failure
4.7.3.6 Cardiac Markers Market, By Congestive Heart Failure
4.7.3.7 Others
4.7.3.8 Cardiac Markers Market, By Others
4.7.4 Cardiac Markers Market, By Marker
4.8 Thyroid Stimulating Hormone
4.8.1 Thyroid Stimulating Hormone Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.8.2 Thyroid Stimulating Hormone Market, By End - Use
4.8.2.1 Thyroid Stimulating Hormone Market, By Hospital
4.8.2.2 Thyroid Stimulating Hormone Market, By Laboratories
4.8.2.3 Thyroid Stimulating Hormone Market, By Home Care
4.8.2.4 Thyroid Stimulating Hormone Market, By Clinic
4.8.2.5 Thyroid Stimulating Hormone Market, By Physician Office
4.8.2.6 Thyroid Stimulating Hormone Market, By Pharmacy & Retail Clinics
4.8.2.7 Thyroid Stimulating Hormone Market, By Non - Practice Clinics
4.8.2.8 Thyroid Stimulating Hormone Market, By Urgent Care Clinics
4.8.2.9 Thyroid Stimulating Hormone Market, By Others
4.8.2.10 Thyroid Stimulating Hormone Market, By Rural Health Clinic
4.8.2.11 Thyroid Stimulating Hormone Market, By Federally Qualified Health Clinic (Fqhc)
4.8.3 Thyroid Stimulating Hormone Market, By Disease
4.8.3.1 Hyperthyroidism
4.8.3.2 Thyroid Stimulating Hormone Market, By Hyperthyroidism
4.8.3.3 Hypothyroidism
4.8.3.4 Thyroid Stimulating Hormone Market, By Hypothyroidism
4.9 Hematology
4.9.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.9.2 Hematology Market, By End - Use
4.9.2.1 Hematology Market, By Hospital
4.9.2.2 Hematology Market, By Laboratories
4.9.2.3 Hematology Market, By Home Care
4.9.2.4 Hematology Market, By Clinic
4.9.2.5 Hematology Market, By Physician Office
4.9.2.6 Hematology Market, By Pharmacy & Retail Clinics
4.9.2.7 Hematology Market, By Non - Practice Clinics
4.9.2.8 Hematology Market, By Urgent Care Clinics
4.9.2.9 Hematology Market, By Others
4.9.2.10 Hematology Market, By Rural Health Clinic
4.9.2.11 Hematology Market, By Federally Qualified Health Clinic (Fqhc)
4.9.3 Hematology Market, By Disease
4.9.3.1 Anemia
4.9.3.2 Hematology Market, By Anemia
4.9.3.3 Leukemia
4.9.3.4 Hematology Market, By Leukemia
4.9.3.5 Others
4.9.3.6 Hematology Market, By Others
4.10 Primary Care Systems
4.10.1 Primary Care Systems Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.10.2 Primary Care Systems Market, By End - Use
4.10.2.1 Primary Care Systems Market, By Hospital
4.10.2.2 Primary Care Systems Market, By Laboratories
4.10.2.3 Primary Care Systems Market, By Home Care
4.10.2.4 Primary Care Systems Market, By Clinic
4.10.2.5 Primary Care Systems Market, By Physician Office
4.10.2.6 Primary Care Systems Market, By Pharmacy & Retail Clinics
4.10.2.7 Primary Care Systems Market, By Non - Practice Clinics
4.10.2.8 Primary Care Systems Market, By Urgent Care Clinics
4.10.2.9 Primary Care Systems Market, By Others
4.10.2.10 Primary Care Systems Market, By Rural Health Clinic
4.10.2.11 Primary Care Systems Market, By Federally Qualified Health Clinic (Fqhc)
4.11 Decentralized Clinical Chemistry
4.11.1 Decentralized Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.11.2 Decentralized Clinical Chemistry Market, By End - Use
4.11.2.1 Decentralized Clinical Chemistry Market, By Hospital
4.11.2.2 Decentralized Clinical Chemistry Market, By Laboratories
4.11.2.3 Decentralized Clinical Chemistry Market, By Home Care
4.11.2.4 Decentralized Clinical Chemistry Market, By Clinic
4.11.2.5 Decentralized Clinical Chemistry Market, By Physician Office
4.11.2.6 Decentralized Clinical Chemistry Market, By Pharmacy & Retail Clinics
4.11.2.7 Decentralized Clinical Chemistry Market, By Non - Practice Clinics
4.11.2.8 Decentralized Clinical Chemistry Market, By Urgent Care Clinics
4.11.2.9 Decentralized Clinical Chemistry Market, By Others
4.11.2.10 Decentralized Clinical Chemistry Market, By Rural Health Clinic
4.11.2.11 Decentralized Clinical Chemistry Market, By Federally Qualified Health Clinic (Fqhc)
4.12 Feces
4.12.1 Feces Point - Of - Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.12.2 Feces Market, By End - Use
4.12.2.1 Feces Market, By Hospital
4.12.2.2 Feces Market, By Laboratories
4.12.2.3 Feces Market, By Home Care
4.12.2.4 Feces Market, By Clinic
4.12.2.5 Feces Market, By Physician Office
4.12.2.6 Feces Market, By Pharmacy & Retail Clinics
4.12.2.7 Feces Market, By Non - Practice Clinics
4.12.2.8 Feces Market, By Urgent Care Clinics
4.12.2.9 Feces Market, By Others
4.12.2.10 Feces Market, By Rural Health Clinic
4.12.2.11 Feces Market, By Federally Qualified Health Clinic (Fqhc)
4.12.3 Feces Market, By Disease
4.12.3.1 Colorectal Cancer
4.12.3.2 Feces Market, By Colorectal Cancer
4.12.3.3 Gi Disorders
4.12.3.4 Feces Market, By Gi Disorders
4.12.3.5 Others
4.12.3.6 Feces Market, By Others

ページTOPに戻る

Table of Contents

Summary

North America Point Of Care Diagnostics Market Growth & Trends

The North America point of care diagnostics market size is expected to reach USD 28.46 billion by 2030, expanding at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to the rise in the geriatric population and the ability of point-of-care (POC) diagnostic tests to deliver immediate results. Furthermore, a rise in funding from the government & private institutions is a key factor driving the industry’s growth. An increase in the adoption of mobile diagnostic devices in the region is also one of the key factors driving demand for POC testing.

An increase in funding from multiple sources, including the U.S. department of defense (DOD), NIH, and private foundations such as the Bill & Melinda Gates Foundation, is expected to drive the market’s growth. For instance, Grand Challenges Canada and the Bill & Melinda Gates Foundation have launched a joint initiative for POC diagnostics. These organizations are involved in the development and integration of different diagnostic components into interoperable POC platforms with “plug-and-play” characteristic features and the capability of running diverse tests from various developers. Research is conducted to incorporate each test on a common platform with a single interface, enabling analysis of different sample specimens using various approaches for analysis.

Such institutions are involved in funding various projects for the development of POC diagnostics to different organizations including California Institute of Technology, Dartmouth College, and Seventh Sense Biosystems. Moreover, NIH, through the Point-of-Care Technologies Research Network, has been funding the development of these technologies for screening infectious diseases & cancer as well as for primary care. In August 2022, Nanopath, Inc. received funding of USD 10 million from Medtech Convergence Fund and Norwest Venture Partners with participation from Green D Ventures and Gingerbread Capital. The funding would help develop POC diagnostics for women’s health.

Key players operating in the market are focusing on collaboration for the development of new products. For instance, in December 2021, QIAGEN and Denovo Biopharma LLC announced a partnership to establish a blood-based companion diagnostic test. Moreover, the companies are also emphasizing on launching of innovative technologies to increase the efficiency of diagnostic testing. For instance, in 2021, F. Hoffmann-La Roche Ltd launched a new blood glucose meter Accu-Chek Instant system, which helped the company expand its personalized diabetes management business.

North America Point Of Care Diagnostics Market Report Highlights

• The growth of the overall market is attributed to the increasing emphasis on point-of-care testing due to superior efficiency and minimal diagnostic turnaround time

• Increase in funding from multiple sources, including the U.S. department of defense (DOD), NIH, and private foundations such as the Bill & Melinda Gates Foundation is expected to increase the launch of new PoC diagnostic technologies in North America

• The infectious diseases product segment held the largest market share owing to the substantial adoption of COVID-19 diagnostic kits and the introduction of new PoC kits for respiratory conditions

• The clinic end-use segment dominated the market with the highest revenue share in 2022. This is attributed to the population’s preference for clinics due to convenience

• The LDT type segment held a marginal share of the North America PoC diagnostics industry in 2022, owing to stringent authority regulations

• The U.S. dominated the market in 2022, due to the presence of key players and the rising support from the government for the development of advanced technologies

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Grand View Research社の臨床検査分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Grand View Research社はどのような調査会社ですか?

グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

北米のPoint Of Care Diagnostics市場規模、シェア、動向分析レポート 製品別（感染症、グルコース検査、心臓マーカー）、タイプ別、エンドユース別（クリニック、ホームケア、病院）、国別、セグメント予測、2023～2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Grand View Research社の臨床検査分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

北米のPoint Of Care Diagnostics市場規模、シェア、動向分析レポート製品別（感染症、グルコース検査、心臓マーカー）、タイプ別、エンドユース別（クリニック、ホームケア、病院）、国別、セグメント予測、2023～2030年